SCS-C006462

(4E)-4-(2-amino-4-oxo-1H-imidazol-5-ylidene)-5-methoxy-1,5,6,7-tetrahydropyrrolo[2,3-c]azepin-8-one

Pathway: Alkaloids Superclass: Histidine alkaloids Class: Imidazole alkaloids

Chemical Structure

Structure of (4E)-4-(2-amino-4-oxo-1H-imidazol-5-ylidene)-5-methoxy-1,5,6,7-tetrahydropyrrolo[2,3-c]azepin-8-one
Loading 3D structure...
3D conformers are computationally generated from SMILES by RDKit for visualization and download; they are not experimental crystal or NMR structures.
Download: SDF SMILES

Source Information

Stylissa massa (NA)
Kingdom Metazoa Phylum Porifera Class Demospongiae Order Axinellida Family Axinellidae Genus Stylissa Species Stylissa massa
South China Sea
DOI: 10.3390/md20070454  · Marine Drugs

Drug-likeness (Lipinski Ro5)

Molecular Weight
275.3 Da
Threshold ≤ 500
ALogP
-1.07
Threshold ≤ 5
H-Bond Donors
4
Threshold ≤ 5
H-Bond Acceptors
5
Threshold ≤ 10
Passes Lipinski Rule of Five — drug-like candidate

Chemical Properties

Molecular Formula:
C12H13N5O3
Molecular Weight:
275.2680 Da
SMILES:
COC1CNC(=O)c2[nH]ccc2/C1=C1\NC(N)=NC1=O
InChIKey:
WDFPZZAIUGWSFU-VQHVLOKHSA-N
InChI:
InChI=1S/C12H13N5O3/c1-20-6-4-15-10(18)8-5(2-3-14-8)7(6)9-11(19)17-12(13)16-9/h2-3,6,14H,4H2,1H3,(H,15,18)(H3,13,16,17,19)/b9-7+
Calculated Properties
ALogP:
-1.071 lipophilicity
TPSA:
121.60 Ų polar surface area
H-Bond Donors:
4
H-Bond Acceptors:
5
Rotatable Bonds:
1
Ring Count:
3 (1 aromatic)
Chiral Centers:
1
Fsp³:
0.2500 fraction sp³ carbon

Database Information

Compound ID:
SCS-C006462
NPClassifier Pathway:
Alkaloids
NPClassifier Superclass:
Histidine alkaloids
NPClassifier Class:
Imidazole alkaloids
Glycoside:
No
NPClassifier Status:
Classified
External Links:

Biological Activity Data

Activity values are displayed only when a quantitative or clearly reported result is available. Tested organisms, cell lines and molecular targets are shown under Target / model.
Activity Assay Target / model Result Reference
Enzyme inhibition IC50 aldose reductase (ALR2) — Structured numeric value is not available in this record; see the primary reference. 10.3390/md20070454 Marine Drugs
Structure enlarged